Τηλέφωνα επικοινωνίας των υπηρεσιών πρόνοιας για το επίδομα AIDS

Φίλτρο
ΝΟΜΟΣ ΔΗΜΟΣ ΤΗΛΕΦΩΝΟ
ΑΙΤΩΛ/ΝΙΑΣΑΓΡΙΝΙΟΥ2641363400
ΑΙΤΩΛ/ΝΙΑΣΑΜΦΙΛΟΧΙΑΣ2642022266
ΑΙΤΩΛ/ΝΙΑΣΙ.Π ΜΕΣΟΛΟΓΓΙΟΥ2631363432
ΑΙΤΩΛ/ΝΙΑΣΝΑΥΠΑΚΤΙΑΣ2634361218
ΑΡΓΟΛΙΔΑΣΝΑΥΠΛΙΕΩΝ2752029243
ΑΡΚΑΔΙΑΣΤΡΙΠΟΛΗΣ2713600418
ΑΡΤΗΣΑΡΤΑΙΩΝ2681362106
ΑΤΤΙΚΗΣΑΓΙΑΣ ΠΑΡΑΣΚΕΥΗΣ2132100603
ΑΤΤΙΚΗΣΑΘΗΝΑΙΩΝ2105210649
ΑΤΤΙΚΗΣΑΙΓΑΛΕΩ2132044824
ΑΤΤΙΚΗΣΑΧΑΡΝΩΝ2102415380
ΑΤΤΙΚΗΣΕΛΕΥΣΙΝΑΣ2131601403
ΑΤΤΙΚΗΣΚΑΛΛΙΘΕΑΣ2109532717
ΑΤΤΙΚΗΣΝΙΚΑΙΑΣ - ΑΓ.ΙΩΑΝΝΗ ΡΕΝΤΗ2132004813
ΑΤΤΙΚΗΣΠΑΛΛΗΝΗΣ2106604718
ΑΤΤΙΚΗΣΠΕΙΡΑΙΩΣ2131601870
ΑΤΤΙΚΗΣΣΑΛΑΜΙΝΑΣ2132027580
ΑΧΑΙΑΣΠΑΤΡΕΩΝ2610390970
ΒΟΙΩΤΙΑΣΛΕΒΑΔΕΩΝ2261024984
ΓΡΕΒΕΝΩΝΓΡΕΒΕΝΩΝ2462353038
ΔΡΑΜΑΣΔΡΑΜΑΣ2521351123
ΔΩΔΕΚΑΝΗΣΟΥΡΟΔΟΥ2241044741
ΕΒΡΟΥΑΛΕΞΑΝΔΡΟΥΠΟΛΗΣ2551081045
ΕΥΒΟΙΑΣΧΑΛΚΙΔΕΩΝ2221061232
ΕΥΡΥΤΑΝΙΑΣΚΑΡΠΕΝΗΣΙΟΥ2237080238
ΖΑΚΥΝΘΟΥΖΑΚΥΝΘΟΥ2695042544
ΗΛΕΙΑΣΠΥΡΓΟΥ2621360430
ΗΜΑΘΙΑΣΒΕΡΟΙΑΣ2331351918
ΗΡΑΚΛΕΙΟΥΗΡΑΚΛΕΙΟΥ2813409530
ΘΕΣΠΡΩΤΙΑΣΗΓΟΥΜΕΝΙΤΣΑΣ2665099983
ΘΕΣΣΑΛΟΝΙΚΗΣΘΕΣΣΑΛΟΝΙΚΗΣ2313330322
ΙΩΑΝΝΙΝΩΝΙΩΑΝΝΙΤΩΝ2651001041
ΚΑΒΑΛΑΣΚΑΒΑΛΑΣ2513503348
ΚΑΡΔΙΤΣΑΣΚΑΡΔΙΤΣΑΣ2441354719
ΚΑΣΤΟΡΙΑΣΚΑΣΤΟΡΙΑΣ2467350206
ΚΕΡΚΥΡΑΣΚΕΡΚΥΡΑΣ2661035395
ΚΕΦΑΛΛΗΝΙΑΣΚΕΦΑΛΛΟΝΙΑΣ-ΙΘΑΚΗΣ2671022506
ΚΙΛΚΙΣΚΙΛΚΙΣ2341352277
ΚΟΖΑΝΗΣΚΟΖΑΝΗΣ2461029497
ΚΟΡΙΝΘΙΑΣΚΟΡΙΝΘΙΩΝ2741085890
ΚΥΚΛΑΔΩΝΣΥΡΟΥ - ΕΡΜΟΥΠΟΛΗΣ2281079648
ΛΑΚΩΝΙΑΣΣΠΑΡΤΗΣ2731022226
ΛΑΡΙΣΑΣΛΑΡΙΣΣΑΙΩΝ2413549225
ΛΑΣΙΘΙΟΥΑΓΙΟΥ ΝΙΚΟΛΑΟΥ2841340391
ΛΕΣΒΟΥΛΕΣΒΟΥ2251048214
ΛΕΣΒΟΥΛΗΜΝΟΥ2254024011
ΛΕΥΚΑΔΟΣΛΕΥΚΑΔΑΣ2645360615
ΜΑΓΝΗΣΙΑΣΒΟΛΟΥ2421353162
ΜΕΣΣΗΝΙΑΣΚΑΛΑΜΑΤΑΣ2721361858
ΞΑΝΘΗΣΞΑΝΘΗΣ2541350124
ΠΕΛΛΑΣΕΔΕΣΣΑΣ2381351275
ΠΙΕΡΙΑΣΚΑΤΕΡΙΝΗΣ2351351280
ΠΡΕΒΕΖΗΣΠΡΕΒΕΖΑΣ2682089214
ΡΕΘΥΜΝΟΥΡΕΘΥΜΝΗΣ2831341243
ΡΟΔΟΠΗΣΚΟΜΟΤΗΝΗΣ2531022535
ΣΑΜΟΥΣΑΜΟΥ2273080411
ΣΕΡΡΩΝΣΕΡΡΩΝ2321055656
ΤΡΙΚΑΛΩΝΤΡΙΚΚΑΙΩΝ2431063201
ΦΘΙΩΤΙΔΑΣΛΑΜΙΕΩΝ2231350125
ΦΛΩΡΙΝΑΣΦΛΩΡΙΝΑΣ2385044479
ΦΩΚΙΔΑΣΔΕΛΦΩΝ2265350531
ΧΑΛΚΙΔΙΚΗΣΠΟΛΥΓΥΡΟΥ2371351449
ΧΑΝΙΩΝΧΑΝΙΩΝ2821341691
ΧΙΟΥΧΙΟΥ2271350050


Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-NaΓ―ve HIV-1 Infected Adults with Transmitted Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance Mutations

Fri, 16 Aug 2019 00:00:00 GMT-05:00 - Wong, Alexander; Goldstein, Deborah; Mallolas, Josep; DeJesus, Edwin; Johnson, Margaret; Molina, Jean-Michel; Pozniak, Anton; Rodgers, Anthony; Teal, Valerie; Hepler, Deborah; Kumar, Sushma; Sklar, Peter; Hanna, George J; Hwang, Carey; Badshah, Cyrus; Teppler, Hedy

Diagnostic accuracy of oral mucosal transudate tests compared to blood-based rapid tests for HIV among children ages 18 months to 18 years in Kenya and Zimbabwe

Fri, 16 Aug 2019 00:00:00 GMT-05:00 - Chikwari, Chido Dziva; Njuguna, Irene N.; Neary, Jillian; Rainer, Crissi; Chihota, Belinda; Slyker, Jennifer A.; Katz, David A.; Wamalwa, Dalton C.; Oyiengo, Laura; Bandason, Tsitsi; McHugh, Grace; Dauya, Ethel; Mujuru, Hilda; Stewart, Kearsley A; John-Stewart, Grace C.; Ferrand, Rashida A.; Wagner, Anjuli D.
Εισαγωγή: Gaps persist in HIV testing for children who were not tested in prevention of mother-to-child HIV transmission programs. Oral mucosal transudate rapid HIV tests (OMT) have been shown to be highly sensitive in adults but their performance has not been established in children.
Μέθοδοι: ART-naΓ―ve children aged 18 months to 18 years in Kenya and Zimbabwe were tested for HIV using rapid OraQuick ADVANCE Rapid HIV/2 Antibody test on oral fluids (OMT) and blood-based rapid diagnostic testing (BBT). BBT followed Kenyan and Zimbabwean national algorithms. Sensitivity and specificity were calculated using the national algorithms as the reference standard.
Αποτελέσματα: A total of 1,776 children were enrolled; median age was 7.3 years (IQR: 4.7, 11.6). Among 71 children positive by BBT, 71 were positive by OMT (sensitivity: 100% [97.5%CI: 94.9-100%]). Among the 1,705 children negative by BBT, 1,703 were negative by OMT (specificity: 99.9% [95%CI: 99.6-100.0%]). Due to discrepant BBT and OMT results, 2 children who initially tested BBT negative and OMT positive were subsequently confirmed positive within 1 week by further tests. Excluding these 2 children, the sensitivity and specificity of OMT compared to BBT were each 100% (97.5%CI: 94.9-100% and 99.8-100%, respectively).
Συμπεράσματα: Compared to national algorithms, OMT did not miss any HIV-positive children. These data suggest that OMTs are valid in this age range. Future research should explore the acceptability and uptake of OMT by caregivers and health workers to increase pediatric HIV testing coverage. Corresponding Author: Chido Dziva Chikwari Biomedical Research and Training Institute 10 Seagrave Road, Avondale Harare, Zimbabwe Tel: +263772773879/+2634745583 Email: Chido.DzivaChikwari@lshtm.ac.uk The authors report no conflicts of interest related to this work. * Joint first authors Funding: The study in Zimbabwe was jointly funded by the Duke Global Health Institute, the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID concordat agreement and is also part of the EDCTP2 programme supported by the European Union (MR/P011268/1). The Saliva Testing and Video Information to Expand Uptake of Pediatric HIV Testing (STEP-UP) study was funded by the National Institutes of Health (NIH; P30 AI027757 [CFAR New Investigator Award; PI: Wagner]) and the Thrasher Research Foundation (A119882). INN, DAK, JN, ADW were supported by P30 AI027757. ADW was also supported by A119882. INN was supported by Fogarty International Centre (FIC) D43TW009783. This publication was supported by the University of Washington Global Center for the Integrated Health of Women, Adolescents, and Children (Global WACh). This publication was funded in part by the University of Washington / Fred Hutch Center for AIDS Research, and NIH funded program under award number AI027757, which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Β© 2019

About us

Στο hivaids.gr, φιλοξενούμε αφιλοκερδώς το "Πρόγραμμα Συνεργασίας" Μονάδων Λοιμώξεων για την ανάπτυξη διαδικτυακής τράπεζας κλινικών παραμέτρων. Το Πρόγραμμα δημιουργήθηκε από έναν γιατρό ειδικό στην HIV λοίμωξη με τη συμμετοχή των Μονάδων: Περισσότερα

% Αναπηρία και HIV

Νέος κανονισμός

Ενιαίος Πίνακας Προσδιορισμού Ποσοστού Αναπηρίας

Ημερολόγιο

@ Διαύγεια

ΔιαύγειαΔι@ύγεια

διαφάνεια στο κράτος

Διαδικτυακές αναρτήσεις διοικητικών αποφάσεων για το HIV/AIDS

Έρευνα

Σας έχει σπάσει ποτέ το προφυλακτικό κατά τη διάρκεια μιας ερωτικής επαφής;
Ναι
Όχι
Δεν χρησιμοποιώ

Επικοινωνία

Newsletter

Ανακοινώσεις

Χρήσιμες πληροφορίες

Τηλεφωνική γραμμή για το HIV/AIDS

210-7222222

Δευτέρα - Παρασκευή
09:00 - 21:00